Package 70771-1858-3

{"route": ["ORAL"], "spl_id": "709dd70b-24e1-435f-8373-02e6dd538b2c", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["1436239", "1437278", "1437283", "1437288"], "spl_set_id": ["9a943af0-1c6d-43c2-830a-f303baa16124"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1858-1)", "package_ndc": "70771-1858-1", "marketing_start_date": "20231113"}, {"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1858-3)", "package_ndc": "70771-1858-3", "marketing_start_date": "20231113"}, {"sample": false, "description": "500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1858-5)", "package_ndc": "70771-1858-5", "marketing_start_date": "20231113"}, {"sample": false, "description": "3 BLISTER PACK in 1 CARTON (70771-1858-8)  / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (70771-1858-2)", "package_ndc": "70771-1858-8", "marketing_start_date": "20231113"}], "brand_name": "Topiramate", "product_id": "70771-1858_709dd70b-24e1-435f-8373-02e6dd538b2c", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70771-1858", "generic_name": "Topiramate", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "200 mg/1"}], "application_number": "ANDA207382", "marketing_category": "ANDA", "marketing_start_date": "20231113", "listing_expiration_date": "20261231"}